Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • ascls.org
    • ascls.org

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society for Clinical Laboratory Science
  • ascls.org
    • ascls.org
  • My alerts
  • Log in
  • My Cart
American Society for Clinical Laboratory Science

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • Follow ASCLS on Twitter
  • Visit ASCLS on Facebook
  • Follow ASCLS on Instagram
  • RSS Feed
Research ArticleFocus: Viral Infections

Hantavirus

Sarah Hawes and John P Seabolt
American Society for Clinical Laboratory Science January 2003, 16 (1) 39-42; DOI: https://doi.org/10.29074/ascls.16.1.39
Sarah Hawes
was a senior CLS student, University of Texas at San Antonio, San Antonio TX when this article was originally written
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John P Seabolt
is Academic Coordinator, Department of Biology, University of Kentucky, Lexington KY
EdD CLS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jpseab01@uky.edu
  • Article
  • Info & Metrics
  • PDF
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

  1. Sarah Hawes
    1. was a senior CLS student, University of Texas at San Antonio, San Antonio TX when this article was originally written
  2. John P Seabolt, EdD CLS⇑
    1. is Academic Coordinator, Department of Biology, University of Kentucky, Lexington KY
  1. Address for correspondence: John P Seabolt, Academic Coordinator, Department of Biology, 101 Morgan Bldg., University of Kentucky, Lexington KY 40506-0225. (859) 257-7652. (859) 257-1717 (fax). jpseab01{at}uky.edu
  1. Identify the geographical area in which the initial endemic of HPS occurred.

  2. Identify the primary means of transmission for hantavirus.

  3. Describe the four phases of clinical manifestations of HPS.

  4. Discuss the pathology and pathophysiology of HPS.

  5. Describe the three diagnostic laboratory tests for HPS established by CDC.

  6. Identify three characteristic hematological and six chemical findings associated with HPS.

  7. Discuss the treatment of and steps to avoid infection with hantavirus.

Extract

Sin Nombre virus (SNV), an emerging pathogen in the United States, was identified in 1993. This hantavirus, a member of the Bunyaviridae family of RNA viruses, is transmitted by its reservoir host Peromyscus maniculatus, the deer mouse. Transmission is by inhalation of aerosolized feces, urine, or saliva from the infected mice. The illness that pursues, hantavirus pulmonary syndrome (HPS), is characterized initially by mild flu-like symptoms, followed by rapid progression to respiratory distress. There is no established therapeutic regimen and treatment is only supportive. Preventive methods include attempts to minimize contact with the rodents since elimination of the virus is not realistic.

In the age of HIV, cancer, and a plethora of emerging infectious diseases, a new virus has brought deadly havoc in the United States and other parts of the world. In 1993, the first documented cases of hantavirus infections appeared in the Four Corners Region of the U.S. Because of mysterious deaths due to adult respiratory distress syndrome (ARDS), the Sin Nombre virus (SNV), an RNA virus that belongs to the Bunyaviridae, has silently ascended the mortality charts.1 The initial endemic area, which includes the northeast corner of Arizona, the southeast corner of Utah, the southwest corner of Colorado, and the northwest corner of New Mexico, reported additional deaths in that same year. Since its first occurrence, studies have exposed a proliferation of the organism and the disease it produces, hantavirus pulmonary syndrome (HPS).

The greatest incidence continues to occur in the Four Corners region, but individuals who…

ABBREVIATIONS: BUN = blood urea nitrogen; DIC = disseminated intravascular coagulation; ECMO = extracorporeal membrane oxygenation; ELISA = enzyme linked immunosorbent assay; EPA = Environmental Protection Agency; HFRS = hemorrhagic fever with renal syndrome; HPS = hantavirus pulmonary syndrome; IHC = immunohistochemistry; NO = nitric oxide; PT = prothrombin time; PTT = partial thromboplastin time; RNA = ribonucleic acid; RT-PCR = reverse transcriptase polymerase chain reaction; SNV = Sin Nombre virus

    INDEX TERMS
  • hantavirus
  • hantavirus pulmonary syndrome
  1. Identify the geographical area in which the initial endemic of HPS occurred.

  2. Identify the primary means of transmission for hantavirus.

  3. Describe the four phases of clinical manifestations of HPS.

  4. Discuss the pathology and pathophysiology of HPS.

  5. Describe the three diagnostic laboratory tests for HPS established by CDC.

  6. Identify three characteristic hematological and six chemical findings associated with HPS.

  7. Discuss the treatment of and steps to avoid infection with hantavirus.

  • © Copyright 2003 American Society for Clinical Laboratory Science Inc. All rights reserved.
PreviousNext
Back to top

In this issue

American Society for Clinical Laboratory Science: 16 (1)
American Society for Clinical Laboratory Science
Vol. 16, Issue 1
Winter 2003
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Society for Clinical Laboratory Science.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Hantavirus
(Your Name) has sent you a message from American Society for Clinical Laboratory Science
(Your Name) thought you would like to see the American Society for Clinical Laboratory Science web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Hantavirus
Sarah Hawes, John P Seabolt
American Society for Clinical Laboratory Science Jan 2003, 16 (1) 39-42; DOI: 10.29074/ascls.16.1.39

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Hantavirus
Sarah Hawes, John P Seabolt
American Society for Clinical Laboratory Science Jan 2003, 16 (1) 39-42; DOI: 10.29074/ascls.16.1.39
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • West Nile Virus: An Emerging Virus in North America
  • Dengue Fever in the Western Hemisphere
Show more Focus: Viral Infections

Similar Articles

Keywords

  • hantavirus
  • hantavirus pulmonary syndrome

© 2025 The American Society for Clinical Laboratory Science

Powered by HighWire